590HINDIYEHETAL.enzaviruseshavebeendevelopedandevaluated(6,13,20).However,theseassaysaretechnicallydemandingandpronetocontamination,sincethereactiontubesareopenedaftertheampli cationstep.Real-timeRT-PCRs(whichuseTaqMan,LightCycler,andSmartCyclerchemistries)forthedetectionofin uenzavirusesinclinicalsampleshaverecentlybeende-scribed(10,22,24,26).Theseassaysusea uorescentprobeforthesimultaneousampli cationanddetectionofthePCRproduct.
InthisstudywecomparedtheperformancesofregularRT-PCR,ashellvialindirectimmuno uorescenceassay(SV-IFA),andTCwiththatofthereal-timemultiplexRT-PCR(withTaqManchemistry)withpatientsamplesusedforsurveillanceforin uenzavirusesinIsrael.Threehundredseventyclinicalsamplesfrompatientswereanalyzedbythefourdifferentdi-agnosticassaysduringthe2001–2002in uenzaseasonforthepresenceofin uenzavirusAorBbyusingtwodifferent uorescentprobes(6-carboxy uorescein[FAM]andVIC).
MATERIALSANDMETHODS
Epidemiology.TheIsraelCenterforDiseaseControl,togetherwiththeNa-tionalCenterforIn uenzaintheCentralVirologyLaboratoryandagroupofpediatriciansandfamilyphysiciansinprimarycareservicesfromthecentralandnorthernpartsoftheIsrael,establishedasentinelsystemforthereportingofin uenzavirusactivity(19).Surveillancedataformorbidityfromin uenzacom-prisedclinicalinformationfrompatientswithin uenza-likeillnessesandwerebackedbylaboratoryanalysisofrespiratoryspecimens.
Clinicalspecimens.Athroatswabspecimenandtwonasalswabspecimens,onefromeachnostril,werecollectedfromeachof370individualspresentingwithin uenzaandin uenza-likeillnessesatsentinelpatientclinicsthroughoutIsrael.Healthcareproviderswereeducatedonthepropermethodsofspecimencollection,storage,andtransport.Allthreeswabspecimenscollectedfromeachpatientwereplacedinoneviraltransporttube.Theswabswerekeptat4°Candweretransportedwithin48htoIsrael’sCentralVirologyLaboratoryinmedium199supplementedwith200 gofstreptomycinperml,100Uofpenicillinperml,and121.5Uofnystatinpermlat4°C.Onreceiptofthespecimen,priortoanymanipulationofthespecimen,analiquotwasremovedinatypeIIbiologicalsafetycabinetformolecularanalysisandwasstoredat 70°Cuntilitwastested.Moleculartestingwasperformedeitheronthesamedayorthedayafterreceiptofthesample.PatientsamplesweretestedbyTConthedaythatthespecimenwasreceived.
Virusandbacterialstocks.ThefollowingreferencevirusstrainswereobtainedfromtheAmericanTypeCultureCollection(ATCC;Manassas,Va.):in uenzavirusB/Lee/40(ATCCVR-101);in uenzavirusA/HongKong/8/68(H3N2)(ATCCVR-544);adenovirustype2(ATCCVR-846),parain uenzaviruses1(ATCCVR-94),2(ATCCVR-92),and3(ATCCVR-93);respiratorysyncytialvirus(ATCCVR-1302);andcoxsackievirusgroupA24(ATCCVR-583).Inaddition,clinicalisolatesofin uenzavirusA/140/01H1N1andcytomegalovirus-,Epstein-Barrvirus-,andhumanimmunode ciencyvirus-positivepatientsamplesfromtheyear2001wereusedinthestudy.Avianin uenzavirus(H7N7,H5N3,andH9N2)RNAswerekindlyprovidedbyEsterShihmanterfromtheIsraelVeterinaryInstitute,BeitDagan.Bacterialisolatesfrompatients,includingKleb-siellapneumoniae,Haemophilusin uenzae,Streptococcuspyogenes,Streptococcuspneumoniae,andStaphylococcusaureus,werekindlyprovidedbyGilSmollenfromtheBacteriologyLaboratoryatShebaMedicalCenter.
Cellline,virusisolation,andidenti cation.MDCKcells(MRC201129)weregenerouslyprovidedbytheWorldHealthOrganizationMedicalResearchCoun-cil,London,UnitedKingdom.CellmonolayersinrollertubesweremaintainedinDulbecco’smodi edEagle’smedium(DMEM)supplementedwith10%fetalbovineserum,200 gofstreptomycinperml,100Uofpenicillinperml,and121.5Uofnystatinpermlina37°Cincubator.Patientsampleswerevortexedfor30storesuspendtheclinicalsampletrappedontheswab,and200 lofthepatientsamplewasusedtoinoculateMDCKcellsinduplicate.InoculatedcellsweremaintainedinDMEMsupplementedwith200 gofstreptomycinperml,100Uofpenicillinperml,121.5Uofnystatinperml,and2 goftrypsintypeIX(T-0.134;Sigma)permlandwereincubatedat34°C.Cellcultureswereobservedforcytopathiceffects(CPEs)dailyfor14days.Hemagglutinationwithturkeyredbloodcells(0.5%;vol/vol)andguineapigredbloodcells(0.75%;
J.CLIN.MICROBIOL.
vol/vol)wasperformedwithsamplessuspectedofhavingaCPE.IfnoCPEwasobserved,hemagglutinationwasperformedcontinuouslyuntiltheendoftheincubationperiod.Everyhemagglutination-positiveculturewasidenti edbyusingtheclassicalhemagglutinationinhibitionprocedure(2).Hemagglutinationinhibitionwasperformedwithin uenzavirusantisera(A/NewCaledonia/20/99,A/Panama/2007/99,B/HongKong/22/22001,andB/Victoria/504/2000),whichwereobtainedfromtheWorldHealthOrganizationCollaboratingCenterforIn uenza,CentersforDiseaseControlandPrevention(Atlanta,Ga.).
SV-IFA.MDCKcellsin96-wellplateswereinoculatedwiththepatientsam-ples,incubated,andstainedforin uenzavirusesAandB.Brie y,100 lof2.5 105cells/mlsuspendedinDMEMwithheat-inactivated2%fetalbovineserumwasinoculatedintodifferentwellsandincubatedat34°Cfor4to5h.Afterthecellssettled,50 lofDMEMcontaining2 goftrypsinmlwasadded.Eachpatientsample(50 l)wastheninoculatedintotwowellsonthesameplate.Theplateswerethencentrifugedat700 gfor1hatroomtemperatureandincubatedat34°Cfor48h.Thecellswerethen xedwith80%ice-coldacetoneinphosphate-bufferedsaline.In uenzavirusAandin uenzavirusBantigensweredetectedwithprimaryreferencemousemonoclonalantibodiesforin u-enzavirusesAandBsuppliedbytheCentersforDiseaseControlandPreventionandwithsecondaryantibodiesconsistingofa uoresceinisothiocyanate-conju-gatedF(ab)2fragmentofrabbitanti-mouseimmunoglobulin(Dako-Denmark).AZeissinverted uorescentmicroscopewasusedtoexaminethesamplesforpositivelystainingcells.
RNAextraction.ViralgenomicRNAwasextractedfromthesupernatantsofthepatientsamplesbyusingaQIAampRNAextractionkit(QiagenGmbH,Hilden,Germany),accordingtotheprotocolsuggestedbythemanufacturer.Brie y,clinicalsampleswerehomogenizedbyvortexingfor30s,and140 lwasusedfortheextractionofviralgenomicRNA.TheRNAwaselutedfromthecolumnswith50 lofelutionbuffer.TheRNAwasimmediatelystoredat 70°Caftera5- laliquotwasusedfortheonestepRT-PCRorTaqManreaction.BacterialRNAwasextractedwithanRNeasyMinikit(Qiagen).
MultiplexRT-PCRwithgeldetection.TheprimersusedinthisstudywerepreviouslyreportedbyvanEldenetal.(26).In uenzavirusA-speci cprimerswereselectedtoamplifypartofthein uenzavirusM-proteingene(nucleotidepositions217to405).Thesequencesofthein uenzavirusA-speci cforwardandreverseprimersareasfollows:primerINFA-1,5 -GGACTGCAGCGTAGACGCTT-3 ;primerINFA-2/3,5 -CATyCTGTTGTATATGAGGCCCAT-3 .Ontheotherhand,in uenzavirusB-speci cprimersampli edpartoftheHAgene(nucleotidepositions970to1139).Thesequencesofthein uenzavirusB-speci cforwardandreverseprimersareasfollows:primerINFB-1,5 -AAATACGGTGGATTAAATAAAAGCAA-3 ;primerINFB-2,5 -CCAGCAATAGCTCCGAAGAAA-3 .MultiplexRT-PCRwasperformedbyusingaOne-StepRT-PCRkit(Qiagen).Brie y,5 lofextractedRNAwasaddedtoamastermixturecomposedofanenzymemixture(heterodimericrecombinantRTsOmniscriptandSensiscriptandHotStartTaqDNApolymer-ase),400 Meachdeoxynucleosidetriphosphate,20UofRNaseinhibitor(CPGInc.,LincolnPark,N.J.),andamixtureofin uenzavirusA-speci candin uenzavirusB-speci cprimers,eachata nalconcentrationof20pmol.Theoptimizedpro leinthethermalcycler(PTC-100;MJResearchWatertown,Mass.)was50°Cfor30minand95°Cfor15min,followedby35ampli cationcycles(witheachcycleconsistingofdenaturationat94°Cfor45s,annealingat56°Cfor45s,andsynthesisat72°Cfor1min).Ampli cationwascompletedwithaprolongedsynthesisat72°Cfor10min.Ampliconswerevisualizedbyethidiumbromidestainingfollowingelectrophoresisona2%agarosegel.AnalysisofdiscrepantresultswasperformedbyusingtheprimersdescribedbyPoddar(20),inwhichthein uenzavirusA-speci cprimerswereselectedtoamplifypartofthein u-enzavirusM-proteingene(nucleotidepositions65to400),whilethein uenzavirusB-speci cprimerswereselectedtoamplifypartoftheNSgene(nucleotidepositions37to145).
TaqManRT-PCR.AnABIPRISM7700sequencedetectionsystem(AppliedBiosystems,FosterCity,Calif.)wasusedforampli cationanddetectionofin uenzavirusAandBamplicons.Theprimersandprobesspeci cforin uenzavirusesAandBusedinthisstudywerepreviouslydescribedbyvanEldenetal.(26).Inourstudythein uenzavirusA-speci cprobewaslabeledwithFAMatthe5 end(FAM-5 -CTCAGTTATTCTGCTGGTGCACTTGCCA-3 -TAMRA,whereTAMRAisthequencherdye6-carboxytetramethylrhodamine),whilethein uenzavirusB-speci cprobewaslabeledwithVICatthe5 end(VIC-5 -CACCCATATTGGGCAATTTCCTATGGC-3 -TAMRA).VICisdifferentfromthedyeusedbyvanEldenetal.(26).BothprobeshadthequencherdyeTAMRAattheir3 ends.ThesensitivityoftheTaqManassaywasoptimizedbyevaluatingdifferentconcentrationsofprimers(200,300,600,and900nM)andprobes(100,200,and300nM).Theconcentrationsofprimersusedinthisstudythatgavethebestdetectionlimitswere300nMforin uenzavirus
Evaluation of a multiplex real-time RT-PCR for quantitative and ... 20 U of reverse transcriptase XL (AMV), and 20 U of RNase Inhibitor ...
A multiplex real-time PCR for differential detection and quantification of ...The evaluation of the multiplex real time PCR developed in this study ...
Evaluation of a Multip... 7页 2下载券 HIV-...CERTIFICATE OF ANALYSIS AMV Reverse Transcriptase #...real-time RT-PCR, see protocol on back page. ...
(GeneCore, Shanghai, China), 10 U of AMV reverse transcriptase XL (...Evaluation of a multiplex real-time RT-PCR for quantitative and differential...
swine fever virus by a portable real-time reverse transcriptase PCR assay. ...Evaluation of a multiplex real-time RT-PCR for quantitative and differential...
real-time reverse transcriptase PCR (real time QRT-PCR) by various ...We present here our data on the evaluation of some preanalytical variables ...
All Reverse transcriptase reactions, including no-...RESULTS We proposed a new real-time RT–PCR ...multiplex RT reactions and small RNA cloning for ...
Evaluation of absolute q... 11页 1财富值 Development of Real-Time... ... via an RNA intermediate requiring the activity of a reverse transcriptase. ...
single-step multiplex reverse transcription-PCR ...detection but are also laborious and time-...Evaluation of a rapid optical immunoassay for in?...
multiplex real-time reverse transcriptase-polymerase chain reaction (RT-PCR) ...Evaluation of real-time reverse transcription polymerase chain reaction assays ...
热门文档